# Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)

Study · id `cardio:ct-nct03891277` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03891277](<https://clinicaltrials.gov/study/NCT03891277>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03891277

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1006 participants.

## Technical summary

Registry record NCT03891277. Randomized; quadruple masking; primary purpose treatment. Start 2019-04-01 (actual); primary completion 2021-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 1006 participants (planned count; ClinicalTrials.gov record NCT03891277, source copy `cardio:ctgov-nct03891277-2020-07-13`, retrieved 2026-10-26)
- Started: 2019-04-01 (actual) (ClinicalTrials.gov record NCT03891277, source copy `cardio:ctgov-nct03891277-2020-07-13`, retrieved 2026-10-26)
- Primary completion: 2021-10-31 (anticipated) (ClinicalTrials.gov record NCT03891277, source copy `cardio:ctgov-nct03891277-2020-07-13`, retrieved 2026-10-26)
- Completion: 2021-12-31 (anticipated) (ClinicalTrials.gov record NCT03891277, source copy `cardio:ctgov-nct03891277-2020-07-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03891277, source copy `cardio:ctgov-nct03891277-2020-07-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03891277-2020-07-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)
- Acronym: FAVORITE
- Condition: Vascular Cognitive Impairment
- Condition: Dementia, Vascular
- Condition: Iron-deficiency
- Condition: Cerebral Infarction
- Condition: TIA
- Intervention (Drug): Ferrous succinate
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: aaaa1d45fdd43fde0c427bf850d1741569752eecce797db34e764f0054168c50
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
